Global Prosthetics Leader, Ottobock, Licences Intellectual Property from Ekso Bionics

Ekso Bionics Holdings, Inc., a robotic exoskeleton company, announced today they have formalized a licensing agreement providing intellectual property to Ottobock, the global leader in prosthetics and an innovator in the field of neuro-rehabilitation.

Working together, Ekso Bionics and Ottobock will be able to accelerate the pace of innovation in the field of prosthetics to provide the next generation of assistive mobility options. Ekso Bionics will receive a combination of license and royalty payments in return for licensing two of its patents to Ottobock.

As the world's largest manufacturer of prosthetic components, the Ottobock brand stands for high-quality and technologically outstanding products and services. The mission to restore and maintain human mobility stands behind each and every Ottobock product. The strong conviction that quality of life is closely associated with individual freedom, and independence, has been a major influence throughout the company's 95-year history and is shared by Ekso Bionics. This shared vision gives meaningful alignment to this partnership to better augment human capabilities.

"It's an honor to partner with a world leader like Ottobock. Fundamentally, technology should improve the human experience. At Ekso Bionics, we have created technology and commercialized products that enable individuals with gait impairments to walk again. Partnering with Ottobock opens new doors for our technology to enhance an even broader range of individual's quality of life," said Ekso Bionics co-founder Russ Angold. "My dad is an amputee, and I look forward to seeing him use an Ottobock prosthetic utilizing Ekso Bionics technology."

"We've been intrigued by Ekso Bionics' technology for many years, and are excited to start a formal relationship with their ground-breaking company," said Hans Dietl, Ottobock's Chief Technology Officer. "We look forward to leveraging our respective technologies together with an eye on improving our users' quality of life for years to come."

Ekso Bionics designs, develops, and commercializes exoskeletons, or wearable robots, which have a variety of applications in the medical, military, industrial, and consumer markets. Exoskeletons are ready-to-wear, battery-powered robots that are strapped over the user's clothing, enabling individuals to achieve mobility, strength, and endurance not otherwise possible. Ekso Bionics' lead product, EksoTM, is a wearable bionic suit that enables individuals with any amount of lower extremity weakness to stand up and walk over ground. Ekso is forging a new frontier in rehabilitation for people living with the consequences of stroke, spinal cord injury and other neurological conditions affecting gait.

About Ottobock

For people with limited mobility, Ottobock develops medical technology products and fitting concepts in the fields of Prosthetics, Orthotics, Mobility Solutions (wheelchairs, rehabilitation aids), Neuro-rehabilitation and MedicalCare. Subsidiaries in 50 countries offer quality "Made in Germany" worldwide and employ more than 6,000 people. A family-managed company since its founding in 1919, Ottobock has also been supporting the Paralympic Games with its technical expertise since 1988.

For further information:
Karsten Ley
Director Corporate Communication
Otto Bock HealthCare GmbH, Max-Näder-Str. 15, 37115 Duderstadt, Germany
Phone: +49 (0) 5527 848-3036, Fax: +49 (0) 5527 848-3360
E-mail: [email protected]
Internet: www.ottobock-group.com

About Ekso Bionics

Since 2005, Ekso Bionics has been pioneering the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. The company's first commercially available product called Ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. By designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human capabilities, Ekso Bionics is helping people rethink current physical limitations and achieve the remarkable.

Ekso Bionics is headquartered in Richmond, CA and is listed on the OTC QB under the symbol EKSO. To learn more about Ekso Bionics please visit us at www.eksobionics.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Ekso Bionics. (2019, February 19). Global Prosthetics Leader, Ottobock, Licences Intellectual Property from Ekso Bionics. AZoRobotics. Retrieved on November 21, 2024 from https://www.azorobotics.com/News.aspx?newsID=6415.

  • MLA

    Ekso Bionics. "Global Prosthetics Leader, Ottobock, Licences Intellectual Property from Ekso Bionics". AZoRobotics. 21 November 2024. <https://www.azorobotics.com/News.aspx?newsID=6415>.

  • Chicago

    Ekso Bionics. "Global Prosthetics Leader, Ottobock, Licences Intellectual Property from Ekso Bionics". AZoRobotics. https://www.azorobotics.com/News.aspx?newsID=6415. (accessed November 21, 2024).

  • Harvard

    Ekso Bionics. 2019. Global Prosthetics Leader, Ottobock, Licences Intellectual Property from Ekso Bionics. AZoRobotics, viewed 21 November 2024, https://www.azorobotics.com/News.aspx?newsID=6415.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.